MESO:NASDAQ
Mesoblast Ltd
$13.75
arrow_downward
-1.36%(-0.19) 1D
Oct 8, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MESO...
Open
$13.62
High
$13.76
Low
$13.41
Mkt. cap
1.80B
Avg. vol.
219.36K
Volume
239.03K
52-wk high
$21.49
52-wk low
$13.05
EPS
-$0.44
Beta
2.14
Shares outstanding
129.87M
No. of employees
108
Open
$13.62
High
$13.76
Low
$13.41
Mkt. cap
1.80B
Avg. vol.
219.36K
Volume
239.03K
52-wk high
$21.49
52-wk low
$13.05
EPS
-$0.44
Beta
2.14
Shares outstanding
129.87M
No. of employees
108
News stories
From web sources and news partners
AD HOC NEWS
·
14 hours ago
Mesoblast stock reports fiscal revenue of USD 120.3 million
Profile
Mesoblast Limited is an Australian regenerative medicine company. It seeks to provide treatments for inflammatory ailments, cardiovascular disease, and back pain. The company is led by Silviu Itescu, who founded the company in 2004. Wikipedia
About Mesoblast Ltd